Drug Information

Drug General Information
Drug ID
D03SKC
Former ID
DNCL002876
Drug Name
KRP-104
Synonyms
Antigen inhibitor
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 2 [522106]
Company
ActivX Biosciences
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info Modulator [550202]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 522106ClinicalTrials.gov (NCT00525330) A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone. U.S. National Institutes of Health.
Ref 550202Clinical pipeline report, company report or official report of Activx.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.